Vaccines for COVID-19: the current state of play

dc.creator	Koirala, Archana
dc.creator	Jin Joo, Ye
dc.creator	Khatami, Ameneh
dc.creator	Chiu, Clayton
dc.creator	Britton, Philip N.
dc.date.accessioned	2020-06-19T12:25:18Z
dc.date.available	2020-06-19T12:25:18Z
dc.date.issued	2020
dc.description.abstract	There is a strong consensus globally that a COVID-19 vaccine is likely the most effective approach to sustainably controlling the COVID-19 pandemic. An unprecedented research effort and global coordination has resulted in a rapid development of vaccine candidates and initiation of trials. Here, we review vaccine types, and progress with 10 vaccine candidates against SARS-CoV-2 – the virus that causes COVID-19 - currently undergoing early phase human trials. We also consider the many challenges of developing and deploying a new vaccine on a global scale, and recommend caution with respect to our expectations of the timeline that may be ahead.	pt_BR
dc.identifier.citation	KOIRALA, A. et al. Vaccines for COVID-19: the current state of play. Paediatric Respiratory Reviews, [S.l.], v. 35, p. 43-49, Sept. 2020.	pt_BR
dc.identifier.uri	https://repositorio.ufla.br/handle/1/41485
dc.identifier.uri	https://www.sciencedirect.com/science/article/pii/S1526054220300956	pt_BR
dc.language	en_US	pt_BR
dc.publisher	Elsevier	pt_BR
dc.rights	openAccess	pt_BR
dc.source	Paediatric Respiratory Reviews	pt_BR
dc.subject	COVID-19	pt_BR
dc.subject	Vaccines	pt_BR
dc.subject	Human trials	pt_BR
dc.title	Vaccines for COVID-19: the current state of play	pt_BR
dc.type	Artigo	pt_BR

Arquivos

Agora exibindo 1 - 1 de 1